Background Antiphospholipid antibodies (aPLs) are a heterogenous group of
autoantibodies associated with recurrent miscarriage, stillbirth, foetal growth restriction and …

Aspirin is one of the most frequently used and cheapest drugs in medicine. It belongs to the
non-steroidal anti-inflammatory drugs with a wide range of pharmacological activities …

BACKGROUND Antiphospholipid antibodies (aPL) are a family of auto-antibodies that are
associated with an increased risk of recurrent miscarriage, intrauterine growth restriction and …

Background Obstetric antiphospholipid syndrome (APS) is defined by pregnancy
complications associated with antiphospholipid antibodies (aPL). The mechanisms of the …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Problem Some patients with antiphospholipid syndrome (APS) suffer pregnancy morbidity
(PM) but not vascular thrombosis (VT), whilst others suffer VT only. Therefore, we compared …

Prognosis of pregnancies in women with antiphospholipid syndrome has dramatically
improved over the past two decades using conventional treatment with low molecular weight …

The antiphospholipid syndrome (APS) is diagnosed by the combination of vascular
thrombosis and/or pregnancy morbidity and the detection of antiphospholipid antibodies …

Antiphospholipid syndrome (APS) is a complex thrombo-inflammatory autoimmune disease
characterized by the presence of antiphospholipid antibodies (aPL). Women with APS are at …

Introduction Obstetric morbidity in women with antiphospholipid antibodies (aPLs) may
reflect the adverse effects of aPLs on placental cells such as extravillous trophoblasts and …